2015
Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimüllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012–2013
Seifer DB, Tal O, Wantman E, Edul P, Baker VL. Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimüllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012–2013. Fertility And Sterility 2015, 105: 385-393.e3. PMID: 26515380, DOI: 10.1016/j.fertnstert.2015.10.004.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnti-Mullerian HormoneBiomarkersCryopreservationDatabases, FactualEmbryo TransferFemaleFertilityFertilization in VitroHumansInfertilityLinear ModelsLive BirthLogistic ModelsMiddle AgedMultivariate AnalysisOocyte RetrievalPatient SelectionPregnancyPregnancy RatePregnancy, MultipleReproductive Techniques, AssistedRetrospective StudiesRisk AssessmentRisk FactorsTreatment OutcomeYoung AdultConceptsLive birth rateAntimüllerian hormoneCancellation rateAMH levelsAssisted Reproductive Technology Clinic Outcome Reporting System databaseAssisted reproduction technology (ART) outcomesEmbryo cryopreservation ratesSerum antimüllerian hormoneTotal cancellation rateMultiple birth ratesReporting System databaseCycle startAutologous cyclesClinical pregnancyCycle cancellationPrognostic factorsAMH valuesFresh cyclesCycle outcomePrognostic indicatorAMH concentrationsRetrospective analysisMAIN OUTCOMEEmbryo transferMultivariate analysis
2013
Potential Mechanisms for Racial and Ethnic Differences in Antimüllerian Hormone and Ovarian Reserve
Tal R, Seifer DB. Potential Mechanisms for Racial and Ethnic Differences in Antimüllerian Hormone and Ovarian Reserve. International Journal Of Endocrinology 2013, 2013: 818912. PMID: 24348557, PMCID: PMC3857838, DOI: 10.1155/2013/818912.Peer-Reviewed Original ResearchOvarian reserveAntimüllerian hormoneRacial differencesSerum antimüllerian hormoneSerum AMH levelsVitamin D deficiencyReproductive technology treatmentEthnic differencesImportant clinical implicationsSuch racial differencesAMH levelsD deficiencyInfertility treatmentTreatment outcomesReproductive endocrinologistsReproductive planningEthnic groupsTimely interventionClinical implicationsReproductive agingSensitive biomarkerTechnology treatmentEthnic variationGenetic factorsPotential mechanisms
2012
Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study
Merhi ZO, Seifer DB, Weedon J, Adeyemi O, Holman S, Anastos K, Golub ET, Young M, Karim R, Greenblatt R, Minkoff H. Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study. Fertility And Sterility 2012, 98: 228-234. PMID: 22494925, PMCID: PMC3389125, DOI: 10.1016/j.fertnstert.2012.03.029.Peer-Reviewed Original ResearchConceptsWomen's Interagency HIV StudySerum antimüllerian hormoneAntimüllerian hormoneInsulin levelsHIV StudyAged womenGroup 2Group 1Group 3Serum antimüllerian hormone levelsVitamin D correlateAntimüllerian hormone levelsGlomerular filtration rateLow ovarian reserveRegular menstrual cyclesBody mass indexCross-sectional studyIllicit drug usePremenopausal womenCreatinine levelsOvarian reserveHIV statusMass indexD levelsFiltration rate